Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Prostatic Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Glioblastoma 6Rectal Neoplasms 5Oropharyngeal Neoplasms 5Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Lung Neoplasms 4Burkitt Lymphoma 4Astrocytoma 4Urinary Bladder Neoplasms 3Mouth Neoplasms 3Glioma 3Carcinoma, Squamous Cell 3Adenocarcinoma of Lung 3Rhabdomyosarcoma 2Pancreatic Neoplasms 2Mesothelioma, Malignant 2Lymphoma, Follicular 2Laryngeal Neoplasms 2Hodgkin Disease 2Esophageal Neoplasms 2Carcinoma 2Breast Carcinoma In Situ 2Adenocarcinoma, Bronchiolo-Alveolar 2Wilms Tumor 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Skin Neoplasms 1

Interventions

Vincristine 5merphos 4Methotrexate 4Dexamethasone 4Cytarabine 4Cyclophosphamide 4pegaspargase 3dexamethasone acetate 3dexamethasone 21-phosphate 3blinatumomab 3azathiopurine 3auricularum 3Mercaptopurine 3Leucovorin 3Doxorubicin 3Calcium Dobesilate 3prednylidene 2deltacortene 2asparaginase erwinia chrysanthemi recombinant 2Thioguanine 2Spinal Puncture 2Specimen Handling 2Prednisone 2N,N-dicyclohexyl-isoborneol-10-sulfonamide 2Inotuzumab Ozogamicin 2Asparaginase 2venetoclax 1ofatumumab 1calaspargase pegol 1X-Rays 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma × Radiotherapy × 30 days × Clear all
NCT03914625 2026-05-27

A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia

National Cancer Institute (NCI)

Phase 3 Active not recruiting
6,720 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Down Syndrome, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡